Nephro-Urology Monthly

Published by: Kowsar

The Effect of Vitamin C on Parathyroid Hormone in Patients on Hemodialysis With Secondary Hyperparathyroidism: A Double Blind, Placebo-Controlled Study

Vajihe Biniaz 1 , Eghlim Nemati 2 , Ali Tayebi 1 , * , Mehdi Sadeghi Shermeh 1 and Abbas Ebadi 1
Authors Information
1 Department of Medical Surgical Nursing, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Nephrology and Urology Department, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Nephro-Urology Monthly: November 01, 2013, 5 (5); 962-966
  • Published Online: November 13, 2013
  • Article Type: Research Article
  • Received: May 22, 2013
  • Revised: June 12, 2013
  • Accepted: June 25, 2013
  • DOI: 10.5812/numonthly.12404

To Cite: Biniaz V, Nemati E, Tayebi A, Sadeghi Shermeh M, Ebadi A. The Effect of Vitamin C on Parathyroid Hormone in Patients on Hemodialysis With Secondary Hyperparathyroidism: A Double Blind, Placebo-Controlled Study, Nephro-Urol Mon. 2013 ; 5(5):962-966. doi: 10.5812/numonthly.12404.

Abstract
Copyright © 2013, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Sanadgol H, Bayani M, Mohammadi M, Bayani B, Mashhadi MA. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism. Iran J Kidney Dis. 2011; 5(6): 410-5[PubMed]
  • 2. Gorriz JL, Molina P, Bover J, Barril G, Martin-de Francisco AL, Caravaca F, et al. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study. Nefrologia. 2013; 33(1): 46-60[DOI][PubMed]
  • 3. Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Nephrol Dial Transplant. 2008; 23(6): 2058-63[DOI][PubMed]
  • 4. Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, et al. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem. 2000; 46(5): 697-703[PubMed]
  • 5. Massry SG. Is parathyroid hormone a uremic toxin? Nephron. 1977; 19(3): 125-30[PubMed]
  • 6. Polzin DJ, Osborne CA, Jacob F, Ross S. Textbook of veterinary internal medicine. 2000; : 1634-62
  • 7. Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol. 2005; 16(6): 1803-10[DOI][PubMed]
  • 8. Martin KJ, Gonzalez EA. Strategies to minimize bone disease in renal failure. Am J Kidney Dis. 2001; 38(6): 1430-6[DOI][PubMed]
  • 9. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12(10): 2131-8[PubMed]
  • 10. Mahdavi-Mazdeh M, Zamyadi M, Norouzi S, Heidary Rouchi A. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran. Iran J Kidney Dis. 2007; 1(1): 25-8[PubMed]
  • 11. McCauley LK, Koh AJ, Beecher CA, Cui Y, Rosol TJ, Franceschi RT. PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis. J Cell Biochem. 1996; 61(4): 638-47[PubMed]
  • 12. Pearce SH, Thakker RV. The calcium-sensing receptor: insights into extracellular calcium homeostasis in health and disease. J Endocrinol. 1997; 154(3): 371-8[PubMed]
  • 13. Deicher R, Ziai F, Bieglmayer C, Schillinger M, Horl WH. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol. 2005; 16(6): 1811-8[DOI][PubMed]
  • 14. Bohm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. Int J Vitam Nutr Res. 1997; 67(4): 262-6[PubMed]
  • 15. Durose CL, Holdsworth M, Watson V, Przygrodzka F. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. J Am Diet Assoc. 2004; 104(1): 35-41[DOI][PubMed]
  • 16. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant. 2002; 17(3): 422-7[PubMed]
  • 17. Handelman GJ. Vitamin C deficiency in dialysis patients--are we perceiving the tip of an iceberg? Nephrol Dial Transplant. 2007; 22(2): 328-31[DOI][PubMed]
  • 18. Farsi Z. [Rabeteye esteres oksidativ va bimarihaye koleye]. Faslnameye amouzeshie daneshkade parastari-e Bagheyatallah. Educ Quar J Nurs Facult Baghyatalah Univ Med Sci. 2007; 27: 22-3
  • 19. Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, et al. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics. 2006; 6(3): 993-1000[DOI][PubMed]
  • 20. Aghazamani M. Renal patients increase 20% yearly. 2011;
  • 21. Dietary Supplement Fact Sheet: Vitamin C.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments